One-Two Punch: FDA Approves Two New Drugs to Treat Gonorrhea

Impossible d'ajouter des articles

Désolé, nous ne sommes pas en mesure d'ajouter l'article car votre panier est déjà plein.

Veuillez réessayer plus tard

Échec de l’élimination de la liste d'envies.

Veuillez réessayer plus tard

Impossible de suivre le podcast

Impossible de ne plus suivre le podcast

One-Two Punch: FDA Approves Two New Drugs to Treat Gonorrhea

Écouter gratuitement

Voir les détails

À propos de ce contenu audio

The FDA recently approved two new medications to treat gonorrhea and they are sorely needed. Give a listen as infectious diseases expert Dr. Jeanne Marrazzo explains why the new drugs are so important in providing a more convenient, oral treatment option against an infection that is increasingly resistant to other therapies. About our guest: In 2023, Dr. Marrazzo was appointed as the sixth Director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health. She previously was Professor of Medicine and Director of the Division of Infectious Diseases at the University of Alabama at Birmingham School of Medicine and as elected to the National Academy of Medicine in 2024. Her research portfolio is broad and includes the relationships between the vaginal microbiome and female reproductive tract infections, HIV pre-exposure prophylaxis, hormonal contraception, and risk of STI/HIV acquisition.

Aucun commentaire pour le moment